Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Shield Therapeutics PLC (STXS)

London
Currency in GBP
Disclaimer
2.03
+0.02(+1.00%)
Closed

STXS Price Commentary

11p needs to be back at 55p before considering selling
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Sees strong prescription growth in the second quarter and first half of 2023. Total prescriptions for second quarter increase 50% to 15,800 compared to the first quarter. In first half of 2023, total prescriptions grow to around 26,300 which exceeds total prescription volumes for all of 2022. The company says that this growth in the first half means Shield is likely to meet its 2023 goal for US Accrufer prescriptions.
Check out takeover offer!
Don't take it up. It's a rip off
7.48 why no good news from Sheild???
Totally agree, this stock is extremely undervalued, should Rushton 50p but patience is required
7.26p this share s under performing...and needs to be back to the heady heights of 35p
Today 12p up 31%
Why has this excellent share dropped so far off a cliff, surely 40p is its net asset value and then with markets opening in the US, a realistic price of 65p.
18p
21p well that's a shocker... And from being 15%up its now shocking... Has to be a BUY at 21p
why is the sp dropping when the forecast for 2022 is in excess of £2.65p per share... what's happening ?? anyone bhave substantive knowledge
41p why the drop BUYING Opportunity?? Advice
Every dip is oppty to buy
Anonanon should they get anywhere near the bottom of your estimate, I'll be both happy and a rich guy... 160p would be a new house abroad..... I see 80p medium term and 140p by end of 2022..
Im not taking profit until in the 100s
Anon anon me neither and today is a buying opportunity
Bear case: 60 to 80Base: 100 to 120Bull case: 160
Excellent gains over the past 2 days... (countered on my portfolio by IAG and TUI) it would be nice if it gets to 65 and then onto 100p.... It would make a great start to the new year
hopefully yes
Long term tgt 160 (4x from today's price)
Ananoon. What makes you say that... Cause they are finally rising?
12x projected earning in 2023
BUY upto 60p then HOLD
42p good rises.... Heading towards 60p...
does anyone have any news have been into shield for over a year.... hopefully another 30% tomorrow
A steal at this price
Will go 2x from now at least after securing Accufer payer coverage in the US
You say 2x here then 4 times above.... Which is it and do you hold the share
At least 2x. Long term tgt 4x
oh dear, down 29.15
34.5p in a very bad Friday... Excellent company now double down
34p great value and tine to double down... Tgt 45p +
37p definitely get in now because 45p is coming...3-6 month's. by June 2022
keeping this. fair value 25.51 and 98.6% undervalued. Big opportunity.
36p Time to buy into this amazing company at 36.00p and my short/med term expectation is 45p then upto 65p.
46p today...... I thank you
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.